Author Topic: Immune-suppressed patients in Ontario eligible for earlier COVID-19 vaccine  (Read 64 times)

0 Members and 2 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest

This applies to people with MS in Ontario taking Ocrevus, Rituxan (rituximab), or Kesimpta (ofatumumab):

From CBC News (June 2, 2021)--"More Immune-Suppressed Patients in Ontario Eligible for Earlier COVID-19 Vaccine":


https://www.cbc.ca/news/canada/kitchener-waterloo/more-immune-suppressed-patients-in-ontario-eligible-for-earlier-second-covid-19-vaccine-1.6050229
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
60 Views
Last post January 13, 2021, 02:32:50 pm
by agate
0 Replies
36 Views
Last post June 15, 2021, 04:41:03 pm
by agate
0 Replies
44 Views
Last post August 21, 2021, 09:15:22 pm
by agate
0 Replies
52 Views
Last post September 17, 2021, 08:18:27 pm
by agate
0 Replies
35 Views
Last post December 13, 2022, 03:12:39 pm
by agate